Equities

Decibel Cannabis Company Inc

DB:CVE

Decibel Cannabis Company Inc

Actions
  • Price (CAD)0.075
  • Today's Change0.005 / 7.14%
  • Shares traded7.01k
  • 1 Year change-48.28%
  • Beta1.0378
Data delayed at least 15 minutes, as of Nov 15 2024 14:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Decibel Cannabis Company Inc. is a Canada-based consumer-focused cannabis company. The Company is focused on premium cannabis flower, vape, cannabis infused, and concentrate products, created through a vertically integrated business model. Its brands General Admission, Qwest, and Vox are among its portfolio, sold across Canada. The principal products produced and sold by the Company are ultra-premium cannabis flowers, vape cartridges, cannabis infused products, cannabis extracts, cannabis pre-rolls, and, on occasion, bulk amounts of cannabis biomass to other licensed producers in Canada. Its cannabis brands include Qwest, Qwest Reserve, Blendcraft by Qwest, Vox, and General Admission. Qwest cannabis is a small batch grown, nourished with glacial mountain water, hang dried, hand trimmed and cured. Its strains are hand selected based on aroma, flavor and effect, then blended for a smooth smoking experience. It also has AgMedica facility in Chatham, Ontario, as well as a licensed nursery.

  • Revenue in CAD (TTM)101.04m
  • Net income in CAD-563.00k
  • Incorporated2018
  • Employees--
  • Location
    Decibel Cannabis Company Inc1440 - 140, 4th Avenue SWCALGARY T2P 3N3CanadaCAN
  • Phone+1 (416) 459-6306
  • Websitehttps://decibelcc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kane Biotech Inc757.12k-5.48m16.48m--------21.77-0.0420.03740.0059-0.00550.15680.37513.23---113.43-77.89----60.5443.27-723.31-241.850.5679-4.731.43---94.42-20.26-17.29---19.41--
Devonian Health Group Inc9.75m-3.17m19.27m6.00--1.44--1.98-0.0216-0.02160.06650.090.442333.072.321,625,238.00-14.37-21.02-23.15-23.9630.9529.96-32.50-131.971.06-9.410.1406--1.74-5.83-33.39------
Medipharm Labs Corp37.76m-13.49m28.77m166.00--0.6043--0.7621-0.0378-0.03780.10330.11580.56622.753.82227,451.80-20.22-32.88-24.86-39.5623.80-5.88-35.72-67.662.33--0.0557--49.4926.5256.37---49.66--
Charlotte's Web Holdings Inc76.68m-62.44m29.92m164.00--0.5942--0.3902-0.4046-0.40460.49590.31980.35611.3425.09467,583.80-29.00-25.71-33.48-29.0348.0748.98-81.43-63.112.07-42.570.5481---14.82-1.9059.88---7.88--
Decibel Cannabis Company Inc101.04m-563.00k30.98m----0.66479.430.3066-0.0016-0.00960.23490.10530.75551.646.86---0.421-3.55-0.6781-5.1926.7015.77-0.5572-7.130.3644-3.030.5178--46.18--60.33---32.45--
Medicus Pharma Ltd0.00-16.49m35.25m----3.89-----3.58-3.580.000.83610.00-------267.24-652.37-371.17-------------20.260.0549-------300.86------
Data as of Nov 15 2024. Currency figures normalised to Decibel Cannabis Company Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.